000 01394 a2200385 4500
005 20250518005110.0
264 0 _c20191025
008 201910s 0 0 eng d
022 _a2051-1426
024 7 _a10.1186/s40425-018-0432-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJitschin, Regina
245 0 0 _aCD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
_h[electronic resource]
260 _bJournal for immunotherapy of cancer
_c11 2018
300 _a116 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_ximmunology
650 0 4 _aMale
650 0 4 _aMonocytes
_xmetabolism
650 0 4 _aMyeloid-Derived Suppressor Cells
_ximmunology
650 0 4 _aSialic Acid Binding Ig-like Lectin 3
_xmetabolism
700 1 _aSaul, Domenica
700 1 _aBraun, Martina
700 1 _aTohumeken, Sehmus
700 1 _aVölkl, Simon
700 1 _aKischel, Roman
700 1 _aLutteropp, Michael
700 1 _aDos Santos, Cedric
700 1 _aMackensen, Andreas
700 1 _aMougiakakos, Dimitrios
773 0 _tJournal for immunotherapy of cancer
_gvol. 6
_gno. 1
_gp. 116
856 4 0 _uhttps://doi.org/10.1186/s40425-018-0432-9
_zAvailable from publisher's website
999 _c29012723
_d29012723